Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
SkyePharma AG
With
Abbott
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects with documented history of mild to moderate asthma currently taking a stable dose of inhaled corticosteroid
You may not be if
Participation in a prior FlutiForm study
Smoking history within the last 12 months,
Significant, non-reversible, pulmonary disease
Life-threatening asthma within the last year
Clareo Health | Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma